179 related articles for article (PubMed ID: 31745677)
1. The role of fibroblast activation protein in progression and development of osteosarcoma cells.
Zhang L; Yang L; Xia ZW; Yang SC; Li WH; Liu B; Yu ZQ; Gong PF; Yang YL; Sun WZ; Mo J; Li GS; Wang TY; Wang K
Clin Exp Med; 2020 Feb; 20(1):121-130. PubMed ID: 31745677
[TBL] [Abstract][Full Text] [Related]
2. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
[TBL] [Abstract][Full Text] [Related]
3. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
4. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
Yuan D; Liu B; Liu K; Zhu G; Dai Z; Xie Y
J Surg Oncol; 2013 Sep; 108(3):157-62. PubMed ID: 23813624
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
[TBL] [Abstract][Full Text] [Related]
7. Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
Dohi O; Ohtani H; Hatori M; Sato E; Hosaka M; Nagura H; Itoi E; Kokubun S
Histopathology; 2009 Oct; 55(4):432-40. PubMed ID: 19817894
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment.
Wang ZX; Guo MY; Ren J; Li GS; Sun XG
Orthop Surg; 2020 Aug; 12(4):1253-1260. PubMed ID: 32558212
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Huang Y; Simms AE; Mazur A; Wang S; León NR; Jones B; Aziz N; Kelly T
Clin Exp Metastasis; 2011 Aug; 28(6):567-79. PubMed ID: 21604185
[TBL] [Abstract][Full Text] [Related]
12. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.
Wang ZX; Ren SC; Chang ZS; Ren J
Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709
[TBL] [Abstract][Full Text] [Related]
13. FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.
Jia J; Martin TA; Ye L; Jiang WG
BMC Cell Biol; 2014 May; 15():16. PubMed ID: 24885257
[TBL] [Abstract][Full Text] [Related]
14. NFIL3 Acts as a Nuclear Factor to Increase Osteosarcoma Progression.
Xu J; Xu G; Zhang T; Chen T; Zhao W; Wang G
Biomed Res Int; 2019; 2019():4068521. PubMed ID: 31886210
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
17. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
18. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway.
Liu Y; Xi Y; Chen G; Wu X; He M
J Orthop Surg Res; 2020 Jun; 15(1):226. PubMed ID: 32552851
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.
Zi FM; He JS; Li Y; Wu C; Wu WJ; Yang Y; Wang LJ; He DH; Yang L; Zhao Y; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Biol Ther; 2014 Oct; 15(10):1413-22. PubMed ID: 25046247
[TBL] [Abstract][Full Text] [Related]
20. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]